[1] Yin WJ, Zheng GQ, Chen YF, et al. CT differentiation of malignant peritoneal mesothelioma and tuberculous peritonitis[J]. Radiol Med, 2016, 121(4):253-260. DOI:10.1007/s11547-015-0609-y.
[2] 李现军, 李凤岐, 韩建奎, 等. 18F-FDG PET/CT检査中腹腔积液SUV对不明原因腹腔积液的辅助诊断价值[J].中华核医学与分子影像杂志, 2013, 33(6):421-425. DOI:10.3760/cma.j.issn.2095-2848.2013.06.005.
Li XJ, Li FQ, Han JK, et al. The role of standardized uptake value in 18F-FDG PET/CT for auxiliary diagnosis of ascites with unknown cause[J]. Chin J Nucl Med Mol Imaging, 2013, 33(6):421-425.  doi: 10.3760/cma.j.issn.2095-2848.2013.06.005
[3] 王春辉, 王晶.卵巢外腹膜浆液性乳头状癌诊疗进展[J].现代肿瘤医学, 2015(7):998-1001. DOI:10.3969/j.issn.1672-4992. 2015. 07.34.
Wang CH, Wang J. Diagnosis and the latest progress about extraovarian peritoneal serous carcinoma[J]. J Mod Oncol, 2015(7):998-1001.  doi: 10.3969/j.issn.1672-4992.2015.07.34
[4] 陈华, 黄建瑾.原发性腹膜癌病因及治疗进展[J].中国实用妇科与产科杂志, 2006, 22(6):466-468. DOI:10.3969/j.issn.1005-2216.2006.06.029.
Chen H, Huang JJ. The etiology and treatment progress of primary peritoneal carcinoma[J]. Chin J Pract Gynecol Obste, 2006, 22(6):466-468.  doi: 10.3969/j.issn.1005-2216.2006.06.029
[5] 皮亚平, 田柳.肿瘤标志物CA153、CA125联合检查对乳腺癌诊断的价值分析[J].实用癌症杂志, 2017, 32(8):1351-1353. DOI:10.3969/j.issn.1001-5930.2017.08.039.
Pi YP, Tian L. Value of Combined Examination of Tumor Markers CA125 and CA153 in the Diagnosis of Breast Cancer[J]. Pract J Cancer, 2017, 32(8):1351-1353.  doi: 10.3969/j.issn.1001-5930.2017.08.039
[6] 胡望平, 叶桂云, 池细俤, 等. CA153等在乳腺癌肺癌及几种疾病中的应用[J].中国实验诊断学, 2007, 11(6):772-775. DOI:10.3969/j.issn.1007-4287.2007.06.023.
Hu WP, Ye GY, Chi XD, et al. Application of CA153 assay for breast cancer and pulmonary carncinoma and so on malignant and benign diseases[J]. Chin J Laboratory Diagnosis, 2007, 11(6):772-775.  doi: 10.3969/j.issn.1007-4287.2007.06.023
[7] 王菲, 狄丽平, 赵宁, 等.不同化疗方式联合手术治疗中晚期宫颈癌的临床研究[J].饮食保健, 2016, 3(19):24.
Wang F, Di LP, Zhao N, et al. The clinical research of middle-advanced cervical carcinoma treated by different chemotherapy combined with operation[J]. Diet Health, 2016, 3(19):24.
[8] Emoto S, Ishigami H, Yamashita H, et al. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination[J]. Gastric Cancer, 2012, 15(2):154-161. DOI:10.1007/s10120-011-0091-8.